Top

Category: Regulatory


Regulatory

Vape shop owners on edge while Trump administration wavers on banning flavored e-cigarettes

November 14, 2019

Via: CNBC

Christian Liriano is glued to his phone these days, anxiously awaiting any news on whether the Trump administration will ban flavored e-cigarettes. Liriano, 27, owns a vape shop called Vape Hangar in Jacksonville, Florida. Two months ago, he thought he […]


Regulatory

DTC Drug Price Transparency: Ball’s in Congress’ Court

November 13, 2019

Via: Forbes

Last week, Senators Durbin (D – Illinois) and Grassley (R – Iowa) attempted to advance the Drug-Price Transparency in Communications Act through unanimous consent, but objections from Senator Toomey (R- Pennsylvania) scuttled the plan to expedite passage of the bill. […]


Regulatory

Juul’s vaping products should be completely pulled off the market, says ex-FDA chief Gottlieb

November 11, 2019

Via: CNBC

Former FDA Commissioner Scott Gottlieb said Monday that Juul Labs’ products should be removed from the market, citing two studies that showed the scope of teen use of its e-cigarettes and flavored pods. “It’s very clear that Juul can’t keep […]


Regulatory

Rural seasonal workers worry about Montana Medicaid’s work requirements

November 7, 2019

Via: The Medical News

People on Medicaid who work rural seasonal jobs in Montana are wondering about the future of their access to health coverage. Montana recently passed a law that, if it gains federal approval and goes into effect as planned in January, […]


Regulatory

CVS to close 22 drugstores next year

November 6, 2019

Via: CNBC

CVS Health will close 22 “underperforming” drugstores early next year in addition to the 46 stores it shuttered earlier this year, the company said Wednesday in a regulatory filing. The locations weren’t disclosed. The company recorded a $96 million impairment […]


Regulatory

FDA keeps brand-name drugs on a fast path to market ― despite manufacturing concerns

November 5, 2019

Via: The Medical News

After unanimously voting to recommend a miraculous hepatitis C drug for approval in 2013, a panel of experts advising the Food and Drug Administration gushed about what they’d accomplished. “I voted ‘yes’ because, quite simply, this is a game changer,” […]


Regulatory

As Congress works to curb surprise medical bills, N.Y.’s fix gets examined

November 5, 2019

Via: The Medical News

Lobbying campaigns and legislative battles have been underway for months as Congress tries to solve the problem of surprise billing, when patients face often exorbitant costs after they unknowingly receive care from an out-of-network doctor or hospital. As Congress considers […]


Regulatory

Hospitals take shot at opioid makers over cost of treating uninsured for addiction

October 29, 2019

Via: The Medical News

While thousands of cities and counties have banded together to sue opioid makers and distributors in a federal court, another group of plaintiffs has started to sue on their own: hospitals. Hundreds of hospitals have joined in a handful of […]


Regulatory

Walgreens’ earnings top expectations while store closures weigh on profitability

October 28, 2019

Via: CNBC

Walgreens Boots Alliance’s fiscal fourth-quarter profit slid 55% as the company spent more to shutter unprofitable locations and scaled back its tobacco sales. Still, the drop in its earnings per share wasn’t as bad as expected after adjusting for one-time […]


Regulatory

Biogen CEO ‘reasonably confident’ once-doomed Alzheimer’s drug will be granted FDA approval

October 23, 2019

Via: CNBC

Biogen CEO Michel Vounatsos told CNBC on Wednesday that he is “reasonably confident” the U.S. Food and Drug Administration will approve the drugmaker’s experimental Alzheimer’s drug. “We worked in full transparency with the regulator,” Vounatsos told “Squawk Box,” emphasizing the […]


Clinical Research, Innovation, Regulatory

UK-US alliance launched to boost early cancer detection rates

October 21, 2019

Via: medicaldevice-network.com

The International Alliance for Cancer Early Detection (ACED) is a partnership between Cancer Research UK, Canary Center at Stanford University, the University of Cambridge, the OHSU Knight Cancer Institute, UCL and the University of Manchester. Researchers believe that advancements in […]


Regulatory

House lawmakers increase pressure on the vaping industry with two hearings Wednesday

October 16, 2019

Via: CNBC

House lawmakers are upping the pressure on the e-cigarette industry with two hearings scheduled Wednesday morning looking to rein in the industry and assess its risk as an emerging public health threat. The House Appropriations Committee and an Energy and […]


Regulatory

Drug Price Controls Gaining Traction At Federal And State Levels

October 15, 2019

Via: Forbes

Prescription drug price controls are gaining momentum nationally and also at the state level. Nationally, lowering drug prices using government levers is an area in which there appears to be at least some degree of bipartisan agreement. A form of […]


Regulatory

J&J beats third-quarter earnings expectations on higher prescription drug sales, shares rise

October 15, 2019

Via: CNBC

Johnson & Johnson on Tuesday reported third-quarter earnings and revenue that beat expectations, boosted by higher sales of cancer and other prescription drugs, despite multimillion-dollar legal problems from talc and opioids. Here’s what the company reported compared with Wall Street […]


Regulatory

California’s new transparency law reveals steep rise in wholesale drug prices

October 14, 2019

Via: The Medical News

Drugmakers fought hard against California’s groundbreaking drug price transparency law, passed in 2017. Now, state health officials have released their first report on the price hikes those drug companies sought to shield. Pharmaceutical companies raised the “wholesale acquisition cost” of […]